tetano
Editor, Senior Moderator
NPJ Vaccines
. 2024 Oct 13;9(1):188.
doi: 10.1038/s41541-024-00989-8. Aerosol immunization with influenza matrix, nucleoprotein, or both prevents lung disease in pig
Eleni Vatzia[SUP] #[/SUP][SUP] 1 [/SUP], Basudev Paudyal[SUP] #[/SUP][SUP] 1 [/SUP], Barbara Dema[SUP] 2 [/SUP], Brigid Veronica Carr[SUP] 1 [/SUP], Ehsan Sedaghat-Rostami[SUP] 1 [/SUP], Simon Gubbins[SUP] 1 [/SUP], Bhawna Sharma[SUP] 1 [/SUP], Elliot Moorhouse[SUP] 1 [/SUP], Susan Morris[SUP] 2 [/SUP], Marta Ulaszewska[SUP] 2 [/SUP], Ronan MacLoughlin[SUP] 3 [/SUP], Francisco J Salguero[SUP] 4 [/SUP], Sarah C Gilbert[SUP] 2 [/SUP], Elma Tchilian[SUP] 5 [/SUP]
Affiliations
Current influenza vaccines are strain-specific and require frequent updates to combat new strains, making a broadly protective influenza vaccine (BPIV) highly desirable. A promising strategy is to induce T-cell responses against internal proteins conserved across influenza strains. In this study, pH1N1 pre-exposed pigs were immunized by aerosol using viral vectored vaccines (ChAdOx2 and MVA) expressing matrix (M1) and nucleoprotein (NP). Following H3N2 challenge, all immunizations (M1, NP or NPM1) reduced lung pathology, but M1 alone offered the greatest protection. NP or NPM1 immunization induced both T-cell and antibody responses. M1 immunization generated no detectable antibodies but elicited M1-specific T-cell responses, suggesting T cell-mediated protection. Additionally, a single aerosol immunization with the ChAdOx vaccine encoding M1, NP and neuraminidase reduced lung pathology. These findings provide insights into BPIV development using a relevant large natural host, the pig.
. 2024 Oct 13;9(1):188.
doi: 10.1038/s41541-024-00989-8. Aerosol immunization with influenza matrix, nucleoprotein, or both prevents lung disease in pig
Eleni Vatzia[SUP] #[/SUP][SUP] 1 [/SUP], Basudev Paudyal[SUP] #[/SUP][SUP] 1 [/SUP], Barbara Dema[SUP] 2 [/SUP], Brigid Veronica Carr[SUP] 1 [/SUP], Ehsan Sedaghat-Rostami[SUP] 1 [/SUP], Simon Gubbins[SUP] 1 [/SUP], Bhawna Sharma[SUP] 1 [/SUP], Elliot Moorhouse[SUP] 1 [/SUP], Susan Morris[SUP] 2 [/SUP], Marta Ulaszewska[SUP] 2 [/SUP], Ronan MacLoughlin[SUP] 3 [/SUP], Francisco J Salguero[SUP] 4 [/SUP], Sarah C Gilbert[SUP] 2 [/SUP], Elma Tchilian[SUP] 5 [/SUP]
Affiliations
- PMID: 39397062
- PMCID: PMC11471855
- DOI: 10.1038/s41541-024-00989-8
Current influenza vaccines are strain-specific and require frequent updates to combat new strains, making a broadly protective influenza vaccine (BPIV) highly desirable. A promising strategy is to induce T-cell responses against internal proteins conserved across influenza strains. In this study, pH1N1 pre-exposed pigs were immunized by aerosol using viral vectored vaccines (ChAdOx2 and MVA) expressing matrix (M1) and nucleoprotein (NP). Following H3N2 challenge, all immunizations (M1, NP or NPM1) reduced lung pathology, but M1 alone offered the greatest protection. NP or NPM1 immunization induced both T-cell and antibody responses. M1 immunization generated no detectable antibodies but elicited M1-specific T-cell responses, suggesting T cell-mediated protection. Additionally, a single aerosol immunization with the ChAdOx vaccine encoding M1, NP and neuraminidase reduced lung pathology. These findings provide insights into BPIV development using a relevant large natural host, the pig.